Valsartan Patent Expiration
Valsartan is Used for managing hypertension and reducing cardiovascular mortality in stable patients with left ventricular failure or dysfunction post-myocardial infarction. It was first introduced by Novartis Pharmaceuticals Corp
Valsartan Patents
Given below is the list of patents protecting Valsartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Diovan |
US6294197 (Pediatric) | Solid oral dosage forms of valsartan |
Dec 18, 2017
(Expired) | Novartis |
| Diovan | US6294197 | Solid oral dosage forms of valsartan |
Jun 18, 2017
(Expired) | Novartis |
| Diovan |
US5972990 (Pediatric) | Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
Apr 26, 2017
(Expired) | Novartis |
| Diovan | US5972990 | Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims |
Oct 26, 2016
(Expired) | Novartis |
| Diovan |
US5399578 (Pediatric) | Acyl compounds |
Sep 21, 2012
(Expired) | Novartis |
Valsartan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List